By Nathan Allen

Swiss pharmaceutical company Lonza Group AG (LONN.EB) said Monday that it has signed an agreement to set up a manufacturing plant for biological products in China's Guangzhou province using technology provided by GE Healthcare.

The facility will be based on GE Healthcare's off-the-shelf KUBio manufacturing platform and should come online by 2020, Lonza said.

The plant forms part of a larger biomanufacturing initiative between GE Healthcare and Guangzhou Development District, Lonza said.

Write to Nathan Allen at nathan.allen@dowjones.com

(END) Dow Jones Newswires

December 10, 2018 03:44 ET (08:44 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.
GE Aerospace (NYSE:GE)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more GE Aerospace Charts.
GE Aerospace (NYSE:GE)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more GE Aerospace Charts.